Blood Cell-Derived Microvesicles in Hematological Diseases and beyond
Open Access
- 8 June 2022
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 12 (6) , 803
Abstract
Microvesicles or ectosomes represent a major type of extracellular vesicles that are formed by outward budding of the plasma membrane. Typically, they are bigger than exosomes but smaller than apoptotic vesicles, although they may overlap with both in size and content. Their release by cells is a means to dispose redundant, damaged, or dangerous material; to repair membrane lesions; and, primarily, to mediate intercellular communication. By participating in these vital activities, microvesicles may impact a wide array of cell processes and, consequently, changes in their concentration or components have been associated with several pathologies. Of note, microvesicles released by leukocytes, red blood cells, and platelets, which constitute the vast majority of plasma microvesicles, change under a plethora of diseases affecting not only the hematological, but also the nervous, cardiovascular, and urinary systems, among others. In fact, there is evidence that microvesicles released by blood cells are significant contributors towards pathophysiological states, having inflammatory and/or coagulation and/or immunomodulatory arms, by either promoting or inhibiting the relative disease phenotypes. Consequently, even though microvesicles are typically considered to have adverse links with disease prognosis, progression, or outcomes, not infrequently, they exert protective roles in the affected cells. Based on these functional relations, microvesicles might represent promising disease biomarkers with diagnostic, monitoring, and therapeutic applications, equally to the more thoroughly studied exosomes. In the current review, we provide a summary of the features of microvesicles released by blood cells and their potential implication in hematological and non-hematological diseases.Keywords
This publication has 207 references indexed in Scilit:
- HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44Journal of Clinical Investigation, 2012
- Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 proteinProceedings of the National Academy of Sciences, 2012
- Leukocyte-Derived Microparticles in Vascular HomeostasisCirculation Research, 2012
- Proteolipidic Composition of Exosomes Changes during Reticulocyte MaturationJournal of Biological Chemistry, 2011
- Monocytic microparticles activate endothelial cells in an IL-1β–dependent mannerBlood, 2011
- Differential contributions of monocyte‐ and platelet‐derived microparticles towards thrombin generation and fibrin formation and stabilityJournal of Thrombosis and Haemostasis, 2011
- High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndromeCritical Care, 2011
- Microparticles Carrying Sonic Hedgehog Favor Neovascularization through the Activation of Nitric Oxide Pathway in MicePLOS ONE, 2010
- Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1PLOS ONE, 2009
- Expression, activation, and function of integrin αMβ2 (Mac-1) on neutrophil-derived microparticlesBlood, 2008